[Enzalutamide (prostate cancer) - Addendum to Commission A18-80]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 1953229178
English, German
Original Title:
Enzalutamid (Prostatakarzinom) – Addendum zum Auftrag A18-80
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/en/projects-results/projects/drug-assessment/a19-34-enzalutamide-prostate-cancer-addendum-to-commission-a18-80.11879.html
Year Published:
2019
URL for published report:
https://www.iqwig.de/download/A19-34_Enzalutamid_Addendum-zum-Auftrag-A18-80_V1-0.pdf
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- Nonsteroidal Anti-Androgens
Keywords
- Enzalutamide
- Prostatic Neoplasms – Castration-Resistant
- Benefit Assessment
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.